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A B S T R A C T
Aim: To assess the long-term seizure outcome of Irish patients who underwent resective surgery for
refractory epilepsy since 1975. We also wished to determine the impact of pathology and surgical
technique (with particular reference to neocorticectomy) on seizure outcome.
Methods: A retrospective review of medical notes, radiological and histopathological records, was
undertaken between 1975 and 2005. Missing data was supplemented by telephone calls to patients. One
hundred and ninety-nine patients suited the criteria for inclusion and had at least 1-year follow-up (1–
24 years, mean 7.0 years). Engel’s criteria were used to classify seizure outcome at 1, 2, 5, 10, 15 and>15
years follow-up.
Results: The percentage of patients seizure free at 2, 5, 10, 15 and>15 years were, 56.6%, 41.4%, 44%, 25%
and 31.3%, respectively. Of patients with a pathologically conﬁrmed diagnosis of mesial temporal
sclerosis, 55.6% were seizure free at 10 years. Equivalent ﬁgures for tumour were 62.5%, for cortical
dysplasia, 34.8%, for those without any demonstrable pathologic abnormality, 50%, for dual pathology,
50% and for all others, 33.3%. Of those with 10 years or greater follow-up only 20% of neocorticectomy
patients were in Engel class 1, compared with an average of 58.5% for the other surgical techniques.
Conclusion: Seizure freedom rates for Irish Patients were comparable to other large retrospective
studies. Patients who underwent selective procedures tended to do better than those undergoing lobar
resections, in keeping with international trends. The surgical technique unique to the Irish cohort,
temporal necocorticectomy, had the worst long-term outcome.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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This is the ﬁrst comprehensive audit of the Irish epilepsy
surgery series since the ﬁrst temporal lobectomy was performed
in Dublin in 1975. The National Centre for Epilepsy Surgery was
ofﬁcially established in Beaumont Hospital, Dublin in 1994 and is
the only centre in Ireland that offers surgical treatment of
epilepsy.
The effectiveness of surgery over continued pharmacotherapy
for intractable patients has been established in a recent
randomized controlled trial1 which highlighted the short-term
efﬁcacy of resective surgery. Long-term outcome studies, however,* Corresponding author at: National Epilepsy Surgery Centre, Beaumont Hospital,
Dublin 9, Ireland. Tel.: +353 0061 435 574 795; fax: +353 0061 3 93428580.
E-mail address: odunlea@hotmail.com (O. Dunlea).
1 Deceased.
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.03.001are valuable for both pre- and post-surgical patients, to allow a
fully informed choice for the former and a realistic expectation of
the future for the latter.
While the evolution of epilepsy surgery techniques in
Ireland reﬂected international trends, the origins of the Irish
series are quite unique. Neocorticectomy was a popular surgical
technique when epilepsy surgery was ﬁrst offered in Dublin
(1975–1992) and this centre provides the only substantial
modern series of this technique. A 1992 study2 reported
outcome results for neocorticectomy patients, and this now
allows us to compare this unique surgical technique with the
more typical methods of surgery adopted for epilepsy which
succeeded it.
The focus of this study is the long-term post-operative seizure
outcome of patients who underwent resective surgery for epilepsy.
The pathological diagnoses and surgical techniques used (with
particular reference to neocorticectomy) are also examined to
determine their impact on outcome.vier Ltd. All rights reserved.
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2.1. Sample
The total number of patients who underwent surgery for
epilepsy in Ireland since the ﬁrst operation in 1975 is unknown as
initially formal records were not maintained. Apart from poor
initial record keeping, data collection was hampered by other
issues such as the relocation of the neurosurgical programme in
Dublin to the newBeaumontHospital in the late1980s, and the lack
of national recognition of the epilepsy programme until the 1990s.
Patient names were gathered from various sources including
previous epilepsy research studies at our institution and old
operating room log books. Three hundred and twenty-nine
patients who had undergone surgery for epilepsy were identiﬁed.
Patient criteria for inclusion in this study were as follows: (1)
patient had a pre-operative diagnosis of refractory epilepsy, (2)
had resective surgery with the aim of eliminating seizures or
reducing their frequency or severity, (3) surgery was resective not
functional (e.g. functional hemispherectomy or insertion of a vagal
nerve stimulator) and (4) at least 1-year follow-up information
was available.
Of the 329 patients identiﬁed hospital records were available
for 272 patients. A further 44 patients were excluded according to
the above criteria: 19 patients had acute symptomatic seizures in
the immediate peri-operative period and the aim of their surgery
was removal of a tumour causing mass effect; 15 patients did not
have medical intractability established pre-operatively, and 10
patients had functional surgical procedures leaving 228 patients
for analysis.
2.2. Design and data collection
A retrospective chart review was undertaken. Of the 228
patients, 150 had incomplete chart follow-up information. The
Medical Research Ethics Committee at Beaumont Hospital gave
approval to contact patients by telephone when follow-up
information was incomplete. A letter was ﬁrst sent to the patient’s
general practitioner informing him/her of the study and asking if
there was any reason that it would be inappropriate to attempt to
contact the patient (e.g. if the patient had died). Patients were then
sent an information leaﬂet explaining the aims and objectives of
the study, and requesting that a consent form be returned stating
whether or not they wished to be contacted by telephone. Of the
150 patients with incomplete information, only 50 were success-
fully contacted. The remaining 100 patients were still included in
the study but the number of years of follow-up was less than it
would have been had recent contact been possible. Of the 228
patients whomet the inclusion criteria for this study, there was no
post-operative follow-up for 28 patients and 1 patient died peri-
operatively, leaving 199 patients with follow-up of 1 year or more
(1–24 years of follow-up, mean 7.0 years) (Fig. 1).Fig. 1. Epilepsy sur2.3. Follow-up outcome information
Outcome information, with regard to seizures, was classiﬁed
using Engel’s criteria3 at 1, 2, 5, 10, 15 and >15 years. Class 1
included patients who were completely seizure free, had auras
only or seizures secondary to withdrawal of anti-epileptic drugs.
Class 2 patients had rare disabling or nocturnal seizures only, class
3 patients had aworthwhile seizure reduction, and class 4 included
patients who had an unsatisfactory reduction in seizure frequency,
an unchanged seizure proﬁle, or exacerbation of seizures after
surgery.
2.4. Seizure free deﬁnition
At each of the post-surgical anniversaries the patient’s seizure
status for the year preceding the anniversary was used to assign
them to the appropriate Engel outcome class. For example, a
patient who was followed up for 15 years and remained in Engel
class 1 for each assessment date may not have been totally free of
seizures for the whole duration of follow-up. The patient may have
had seizures during years 2–4 after surgery but entered remission
the year before the year ﬁve anniversary, andwas therefore classed
as seizure free at year ﬁve.
2.5. Pathology
Pathological diagnoses were accepted only if the original
pathology report or a copy of it was available and signed by the
neuropathologist. Patients were classiﬁed into one of the
following seven categories (1) mesial temporal sclerosis—MTS
(MTS described qualitatively on the basis of cell loss and gliosis),
(2) cortical dysplasia—CD, (3) tumour, (4) vascular malforma-
tion, (5) no abnormal histology, (6) other, and (7) dual
pathology.
2.6. Surgical technique
The operation note signed by the neurosurgeon, or a copy of it,
was used to determine the surgical technique. Patients were
classiﬁed into 1 of 5 categories: (1) anterior temporal lobectomy—
ATL, (2) amygdalo-hippocampectomy—AH, (3) neocorticectomy,
(4) lesionectomy, and (5) frontal lobe resection. The technique
used for neocorticectomy has been previously described.4
3. Results
3.1. Overall outcome
One hundred and ninety-nine patients suited the criteria for
inclusion in this study and had at least 1-year follow-up (1–24
years; mean 7.0 years). Table 1 displays the clinical characteristics
of these patients.gery patients.
Table 1
Clinical characteristics of patients.
Characteristic Number
Gender
Female 104
Male 95
Age of epilepsy onset (years)
Mean (SD) 10.7 (8.9)
Range 1 month–48 years
Duration of epilepsy (years)
Mean (SD) 15.8 (10.2)
Range 6 months–43 years
Age at surgery (years)
Mean 26.3 (10.9)
Range 1–61 years
Side of resection
Left 86
Right 113 Fig. 3. Favourable seizure outcome (Engel classes 1 and 2) at 5 and 10 post-
operative years
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operative years respectively is shown in Fig. 2.
3.2. Seizure freedom
Forty-three percent of patients in our study never relapsed, that
is, they remained in Engel class one for the duration of their follow-
up.
3.3. Late relapse
Thirty-four patients (17%) experienced a late relapse of seizures
i.e. seizure recurrence following seizure freedom in the ﬁrst one or
two post-operative years. Twenty of these patients had follow-up
of at least 1 year after relapse and only three (15%) regained their
seizure free status andwere classed as such at last follow-up (3–17
years, mean 9.25).
3.4. Long-term follow-up (15 years or more)
Thirty-two patients had follow-up for 15 years or more (16–24
years, mean 19.3 years) following surgery. Of these, 53.1% (n = 17)
had a favourable outcome (Engel’s class 1 or 2) at last follow-up
and 46.9% (n = 15) an unfavourable outcome (Engel’s class 3 or 4).
Of the former group at last follow-up, 70.6% (n = 12) had a
favourable outcome at each follow-up anniversary and 29.4%
(n = 5) were seizure free for the entire duration of follow-up. Of the
latter group at last follow-up, 60% (n = 9) had been classed as
unfavourable at each follow-up stage and 33.3% (n = 5) wereFig. 2. Seizure outcome for all patients (n = 199).classed as late relapsers. Two patientswith follow-up of 15 years or
more exhibited the ‘‘running down phenomenon’’ (experienced
seizures for the ﬁrst 1–2 post-operative years and subsequently
remitted).
3.5. Pathology
Of the 199 patients with at least 1-year follow-up, 194 had a
neuropathological diagnosis that suited the criteria for inclusion.
The most common pathology was MTS (n = 73) followed by CD
(including neuronal ectopia, heterotopia and neuronal clustering)
(n = 47). The remainingpathologiesweredividedas follows: tumour
(n = 23), vascular (n = 5), no abnormal histology (n = 13), other
(n = 15), and dual pathology (n = 18). Of the 18 patients with dual
pathology—12 had CD and MTS, 2 had astrocytoma and CD, 2 had
ganglioglioma and CD, 1 had oligodendroglioma and CD and 1 had
dysembryoplastic neuroepithelial tumour (DNET) and CD. Of the 15
patients with ‘other’ pathology classiﬁcation—7 patients had
Chaslin’s gliosis insufﬁcient for diagnosis of MTS, 2 had cerebral
contusions, 2 had evidence of infarction, 1 had non-speciﬁc chronic
inﬂammatory change, 1 had neurosarcoidosis, 1 had cortical
hamartoma and1 had a porencephalic cyst. Of the 23 patients with
tumours, 12 had astrocytomas, 4 had gangliogliomas, 4 had
oligodendrogliomas, 2 had oligoastrocytomas and 1 had a DNET.
Figs. 3 and 4 depict the seizure outcome for patients with
different pathological diagnoses at post-operative years ﬁve and
ten. Favourable seizure outcome included patients in Engel’s classFig. 4. Unfavourable seizure outcome (Engel classes 3 and 4) at 5 and 10 years.
Fig. 5. % Patients seizure free according to surgical technique at each surgical
anniversary.
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pathology is not included in this ﬁgure as this pathology group had
follow-up for 1 year only.
Pathology results were compared to determine if there was a
signiﬁcant difference between favourable and unfavourable out-
come at each of the surgical anniversaries. MTS patients had a
signiﬁcantly better outcome over CD, Tumour and other pathology
groups at 1, 2 and 5 years after surgery. There was a borderline
signiﬁcantly better outcome for MTS patients compared with
patients in whom a pathologic abnormality was not demonstrated
over the period of the 1–10-year anniversaries (p < 0.06–0.04).
Dual pathology had signiﬁcantly better results over CD at 1 and 5
years, over vascular pathology at 1 year only, and over other
pathology group at 2 years.
3.6. Surgical technique
Of the 199 patients with at least 1-year follow-up, the surgical
technique suited the criteria for inclusion for 195 patients. ATLwas
the most common operation (n = 74) followed by AH (transcortical
approach) (n = 62), neocorticectomy (n = 34), lesionectomy
(n = 21) and frontal lobe resection (n = 4). The latter two groups
therefore including patients with extra-temporal lobe epilepsy.
The seizure outcome for the various surgical techniques is shown
in Fig. 5. Patients with MTS pathology who underwent AH surgical
technique had signiﬁcantly better outcomes than those who
underwent ATL at the 2-, 5- and 10-year surgical anniversaries
(p < 0.006, p < 0.003, p < 0.006 respectively).
3.7. Neocorticectomy
The percent of neocorticectomy patients with a favourable
outcome at one, two and ﬁve post-operative years was 53%, 51.7%
and 42.3%, respectively. This increased to 60% at 10 years, 66.7% at
15 years and 77.7% at greater than 15 years. The most dramatic
difference in outcome results for surgical techniqueswas between
neocorticectomy and AH. AH had signiﬁcantly better outcomes
over neocorticectomy for follow-up periods 1–10 years
(p < 0.0005). While 91.2% of neocorticectomy patients experi-
enced a relapse at some point during follow-up, only 35.5% of AH
and 68.9% of ATL patients did so. The outcome differences
betweenneocorticectomyandATLwerenot sodistinct. At theﬁfth
post-operative anniversary signiﬁcantly more patients from the
ATL group were in Engel’s class 1 compared to the neocorticect-
omy patients (p < 0.02). The difference did not reach signiﬁcance
at the 1- (p > 0.24), 2- (p = 0.055) or 10-year anniversaries
(p < 0.08).3.8. Mortality
Thirteen of the 199 patients (6.5%) died during the follow-up
period. The cause of death is known in 5 patients. One patient died
from a post-operative haematoma following epilepsy surgery, one
from complications secondary to a seizure, another from a non-
neurological cancer and two from suicide. The mean age at the
time of death for the 13 patients was 35.5 years (range 18–60
years). Death occurred between 0 and 20 years after surgery (mean
8.3 years). Five of thosewho died had been seizure free for at least 2
years before their death.
4. Discussion
This analysis of the Irish epilepsy surgery series demonstrates
that the seizure outcome for Irish patients is favourable and overall
compares well to those from other countries. It also suggests that
those experiencing late relapse tend to have a poor outcome with
regards to achieving complete seizure control, as do those who
underwent neocorticectomy.
Of patients with 5 and 10 years of follow-up, MTS patients were
more likely than any other pathology group to have a favourable
outcome (Engel class 1 or 2). Also there was very little change in
the outcome of MTS patients between the 5th and 10th
anniversaries. Conversely, patients in the pathology group ‘other’
were least likely to have a favourable outcome at the same
anniversaries (Figs. 3 and 4). CD and tumour pathologies were the
only groups to havemore patients with a favourable outcome at 10
years compared with 5 years. The most dramatic deterioration in
outcome was for the dual pathology group, as 81.3% had a
favourable outcome at 5 years but this dropped to 62.5% at 10
years.
The seizure free outcomes for our MTS patients were 75.3%,
72.1%, 59.5%, 55.6% at 1, 2, 5 and 10 years respectively. The
outcome for MTS patients over the same time period in two other
studies5,6 were 67.7%, 62.2%, 54.2% and 47% and 88.8%, 88.8%, 91.3%
and 85.7% respectively. The latter study also reported the 1-year
seizure free outcome for MTS patients for a range of studies from
1995 to 2004 (range: 58–88%, mean 81.5%). Overall 43% of patients
in our study remained seizure free throughout; this is consistent
with results from other studies that range from 45.6 to 55%.7–10
Patients without any demonstrable pathologic abnormality had
similar outcome results to those with MTS. This is in contrast to
other studies11,12 that report that the absence of pathologic change
predicts a poorer outcome compared with other pathologies.
However this was disputed in other reports.13,14
In terms of surgical technique, patients who underwent an AH
had very good short- and long-term outcomes. Throughout the 1–
10-year follow-up at least 77.4% of these patients were classed as
seizure free, and had the highest number seizure free at the 10-
year anniversary (84.6%). The signiﬁcantly better outcome of our
MTS patients who underwent AH compared to ATL (41% seizure
free at 10 years) is in contrast to other recent studies which
reported the opposite15 and no signiﬁcant difference in out-
come.16,17 Patients who underwent AH did not experience a
deterioration in seizure outcome with longer follow-up whereas
those who underwent ATL were less likely to be seizure free at 10
years follow-up than at 1 year. There is no identiﬁable reason for
this discrepancy and our outcome results for ATL patients are
almost identical to those from another large scale study which also
had follow-up of patients who underwent ATL for 15 years or
more.5 The decision for patients to undergo AH or ATL was decided
on a case by case basis, following the ﬁrst AH at our institution
which was performed in 1992. All surgical cases were discussed at
the weekly multi-disciplinary epilepsy meeting. If a patient had
clear clinical and EEG evidence of mesial temporal lobe seizure
Table 2
Comparison of % patients seizure free following resective surgery for epilepsy between different studies.
Year after
surgery
Our results
(n=199)
Salanova et al.
(Ref. 9) (n=145)
Rougier et al.
(Ref. 18) (n=100)
Elwes et al.
(Ref. 19) (n=102)
Jutila et al.
(Ref. 20) (n=140)
Asztely et al.
(Ref. 8) (n=65)
1 59.8% 66% 66% 56% 57% –
2 56.6% 63% 68% 60% – 54%
5 41.4% 60% 51% 67% – –
10 44% 55% – – – –
15 25% – – – – –
>15 31.3% – – – – –
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selective technique.
With regards to achieving seizure freedom neocorticectomy
patients did not do as well as those who underwent other surgical
techniques. The vast majority (91.2%) of neocorticectomy patients
experienced a relapse (perhaps due to the persistence of themesial
temporal structures). An improvement was seen at follow-up
greater than 15 years (16–20 years, mean 17.8 years) with 33.3% of
patients seizure free. Thismay have been due to the introduction of
newer anti-epileptic drugs in these patients. Neocorticectomy was
performed in Dublin when resective surgery for epilepsy was ﬁrst
introduced. The outcome of 50 Irish neocorticectomy patients had
previously been published in 1992.2 This study had followed up
patients from 3 to 15 post-operative years and reported favourable
outcome (deﬁned using Crandall’s criteria which is equivalent to
our deﬁnition of favourable outcome of Engel classes 1 and 2) for
62% of patients. As follow-up for these patients was up to 15 years
the results are similar to our ﬁndings as 66.7% of our neocorti-
cectomywith 15 years or less follow-up had a favourable outcome.
Table 2 compares our results with similar studies.
There was no signiﬁcant difference between our results and
those of the other studies at the ﬁrst and second post-operative
years. Five years after surgery however, with regard to seizures,
two large scale studies9,19 had a signiﬁcantly better outcome than
our study (60% and 67% seizure free, respectively, compared to our
41.4%). This may have been due to inclusion in our study of the
neocorticectomy patients who generally had poorer outcomes
than our other patients. Our results were re-analyzed after
exclusion of the neocorticectomy patients. Resultant ﬁgures are
61.4% seizure free at 2 years and 48.7% at 5 years.
Our results support the long-term efﬁcacy of resective surgery
for epilepsy, but also show (Fig. 2) that with longer follow-up
duration fewer patients are classed as seizure free. Thirty-four
patients (17%) experienced a late relapse of seizures which may
suggest that new epileptogenic pathways may form over time.
Surgery in many instances may be a mere interruption in the
epileptic network of electrical spread, rather than a resection of a
discreet epileptic focus, and the margins of a surgical resection
may in time take over the role of the generator or peak of an
epileptic network. Another possibility is that during epileptogen-
esis, whenever that happens, several potential sites of epileptic
generation may be initiated. One focus becomes dominant, and
following resection gives some years of freedom, before a
secondary site then takes over.
Only three (15%) of the late relapse patients in our studywith at
least 1-year follow-up after relapse (3–17 years, mean 9.25)
regained their seizure free status and were classed as such at last
follow-up. This is in contrast to two other studies21,22 which
reported that 87% and 53%, respectively, of their late relapse
patients regained their seizure free status at end of follow-up. The
former study included patients who relapsed after one seizure free
post-operative year, and the latter included those who relapsed
after ﬁve seizure free years. Therefore, those patients who relapse
later rather than earlier may not have such a good prognosis for
seizure outcome. The mean duration of follow-up after relapse inthe former study21 was 3.7 years and in the latter study22
information regarding duration of follow-up after relapse was not
available. In our study the mean duration length of follow-up was
8.7 years. Our results are more consistent with another study23
which reported that all of their late relapse patients became
refractory to medical treatment. However this study also reported
that late recurrences are seen predominantly in MTS patients; in
our study less than one quarter of our late relapse patients had a
diagnosis of MTS.
Of those with an unfavourable end of follow-up outcome at 15
years or more, 60% had been classed as unfavourable at each stage
of follow-up and 27% were late relapsers. Similarly, 71% of those
with a favourable outcome at last follow-up had been classed as
favourable for each stage of follow-up, 29% of which were seizure
free for the entire duration of follow-up. Therefore, previous post-
operative seizure history is a very good predictor of long-term
outcome. Of patients who relapsed in our study, 80.7% had done so
by the second year after surgery and similar ﬁndings have been
demonstrated by other authors.10,19 Patients, therefore, who have
remained seizure free by the second anniversary have a very good
chance of a long-term favourable outcome.
People with epilepsy have an increased mortality rate
compared with the general population.24 Thirteen patients in
our study died during follow-up (6.5%) and this ﬁgure is similar to
results from other studies that range from 3.4% to 10.9%.5,8–
10,18,20,25–27 Unfortunately cause of death could only be ascertained
for 5 patients. Two patients died by suicide (1%) which is similar to
another study reporting a post-operative suicide rate of 1.6%.25
Resective epilepsy surgery has been performed in Ireland since
1975. Despite the difﬁculties in obtaining outcome information,
this series has shown that the long-term seizure outcome for Irish
patients who underwent surgery for refractory epilepsy compares
favourably with results from other countries. This study also
allowed for the comparison of long-term outcome from an
operation largely unique to this series – the neocorticectomy –
withmore typical methods of surgery adopted for epilepsy. Finally,
this study indicates the presence of a late relapse phenomenon
seen in other long-termoutcome series and the poor prognosis that
is associated with it.
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